ChatCRC, our AI-powered assistant can:
- Answer your #colorectalcancer questions
- Help translate your biomarker report
- Find clinical trials near you
Thank you to Dr. Christopher Lieu (@CUAnschutz) for the shoutout!
Start chatting: https://t.co/1B6brSDiKF
Tomorrow at 8PM ET, the CRC community is coming together for one hour to prepare for what's ahead. Learn how Call-on Congress is evolving, where the Global Early-Onset #CRC Think Tank fits in, & how you can take part. No advocacy experience needed. https://t.co/ATsr5hdFRo
IMPORTANT 🚨 Big changes are coming to Call-on Congress 2027!
Advocates and leading researchers will unite in Washington, DC, to strengthen our fight for #colorectalcancer research funding.
Spots are limited and filled first come, first served within each state. Applications open October 1—mark your calendar and apply early!
Learn more: Call-on Congress 2027: https://t.co/AS1e4HoboV
Have questions? Join us tomorrow at 8:30 p.m. ET for Advocacy Action Hour and get your questions answered live: https://t.co/w5A8wJp00g
A temporary win for #colorectalcancer research and screening, but permanent action is still needed.
Congress's short-term funding bill maintains funding for these critical programs and delays a proposed OMB rule that could harm cancer research through December 11.
Fight CRC urges Congress to pass full-year funding and permanently block the proposed rule. Read our comments to OMB: https://t.co/OZaSg98Xas
Huge congratulations to our partners at Bowel Cancer Australia and Prof Dan Buchanan, on the launch of CRE ARTEMIS! We’re proud to work alongside you to advance early-onset colorectal cancer research. 💙🌏
“My research is grounded in the view that contemporary early-onset bowel cancer is a new type of disease,” ~ A/Prof Dan Buchanan
In this episode of The Bottom Line Podcast, A/Prof Dan Buchanan, recently announced Director of the Centre of Research Excellence (CRE) ARTEMIS, discusses the upcoming five-year research program that will investigate the aetiology, risk factors, tumourigenesis, exposures, microbiome and immune susceptibilities that are underlying early-onset bowel cancer.
Funded by Bowel Cancer Australia, A/Prof Buchanan will lead the $3million Centre’s 22-member team across multiple disciplines looking to molecularly ‘tease apart’ these cancers to pinpoint the role of the gut microbiome in cancer development and develop more targeted approaches to assessing people’s risk that will guide a personalised prevention, screening and care pathway.
https://t.co/5OD6NDHaX2
The Centre was named after the Greek goddess of the hunt, Artemis, reflecting the team’s determination to track down what is causing early-onset bowel cancer and the alarming rise of the disease in young Australians.
Listen now at https://t.co/fUoRDPJxUp or access it wherever you usually get your podcasts.
Thrilled to share Notice of Award for our NCI UG3/UH3 grant Non-Invasive Post-Polypectomy Surveillance Study
Post polypectomy represents 🔑 opportunityfor CRC prevention
🙏 to @NIH for supporting this work and excited to partner with SamirGupta and our team
@NYULH_GastroHep
What's ahead for Call-on Congress, & how does the Global Early-Onset CRC Think Tank fit in? Join fellow CRC advocates at our next Advocacy Action Hour August 17, 8PM ET to connect, learn, & find your place in the work ahead. You won't want to miss this! https://t.co/ATsr5hdFRo
We’re proud to welcome First Ascent Biomedical, @TheVFoundation and The Colorectal Cancer Equity Foundation to the Colorectal Cancer Care Initiative! Their expertise in health equity, cancer research, and precision medicine strengthens our work to close gaps across the CRC care continuum.
Call-on Congress is evolving, and global researchers are joining the fight against early-onset #colorectalcancer.
Learn what's changing, why it matters, and how advocates can help drive progress at our next Advocacy Action Hour. Register now at https://t.co/ATsr5hdFRo
Talking about pain isn't easy. Knowing how to describe what you're feeling can help your care team better support you. ChatCRC can help you describe what you're experiencing & prepare for those important convos. Ask your questions at https://t.co/1ZhhR4EPlO #PainAwarenessMonth
✋ Stop your scroll! Have you heard any of these biomarker misconceptions?
Watch the full webinar: https://t.co/NX7IFesZsy
Thank you to our panelists, gastrointestinal medical oncologist, @VanMorrisMD, and #colorectalcancer survivor and research advocate, @EstebanFGarcia, for sharing their expertise and experience!
Thank you to our sponsors, @pfizer and @NateraGenetics, for supporting this educational webinar.
Thank you to our panelists, Gastrointestinal Medical Oncologist, Dr. Van Morris and #colorectalcancer survivor and Research Advocate Esteban Garcia, for sharing their expertise and experience!
@VanMorrisMD@EstebanFGarcia@UTMDAnderson
Thank you to our sponsors, @pfizer and @NateraOncology, for supporting this education.
Our latest webinar, 'Beyond the Basics' is designed to break down the complex world of biomarker testing into clear, actionable information.
Watch the full webinar now: https://t.co/KltGU6IcGI
This session helps participants better understand the role of tissue testing, circulating tumor DNA (ctDNA), minimal residual disease (MRD) testing, and recurrence monitoring throughout the colorectal cancer journey.